The Imaging Core of the UCLA Alzheimer's Disease Research Center (ADRC) builds on extensive strengths at UCLA for brain imaging. The Imaging and Genetics Core of the past funded period has been reengineered to an Imaging Core that embraces both structural and functional imaging. During the past funded period, we have built a large archive of images of patients assessed cross-sectionally and have followed a cohort of patients with Alzheimer's disease (AD), mild cognitive impairment (MCI), and normal aged controls with longitudinal magnetic resonance imaging (MRI). Images have been used by investigators to construct a preliminary AD atlas. In the renewal period, these longitudinal studies will be extended to include patients with cognitive impairment not dementia (CIND) and patients with frontotemporal dementia (FTD). The Core will provide both structural (MRI) and functional (positron emission tomography; PET) assessments longitudinally. Patients will be assessed and followed for clinical data in the Clinical Core and genetic data will be collected in the Neuropathology and Molecular Genetics Core. The Imaging Core will: (1) collect high quality longitudinal (every two years) structural (MRI) imaging data on a total of 160 individuals consisting of 35 individuals with MCI, 35 with CIND, 20 with FTD, 10 with mild AD, and 40 cognitively intact healthy elderly; (2) collect functional (FDG-PET) imaging on the same cohort; (3) archive all cross-sectional imaging data (MRI, PET, and SPECT) obtained on ADRC subjects as part of their initial and/or follow-up assessments (approximately 1,000 individuals assessed cross-sectionally and 200 prospectively by the end of the renewal period); (4) provide the means for investigators to digitally analyze structural images; 5) develop a core resource for use by investigators to analyze functional images; 6) support other cores and investigators. The Core will interact with a network of related core activities and projects to advance drug development and neurotherapeutics for MCI, CIND, AD, and FTD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG016570-08
Application #
7215223
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
8
Fiscal Year
2006
Total Cost
$137,633
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Joe, Elizabeth; Medina, Luis D; Ringman, John M et al. (2018) 1H MRS spectroscopy in preclinical autosomal dominant Alzheimer disease. Brain Imaging Behav :
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679

Showing the most recent 10 out of 727 publications